TYPE2DIABETES
Clinical trials for TYPE2DIABETES explained in plain language.
Never miss a new study
Get alerted when new TYPE2DIABETES trials appear
Sign up with your email to follow new studies for TYPE2DIABETES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New diabetes device put to the test in Sham-Control group
Disease control Not yet recruitingThis study looks at the safety and performance of the Endogenex System in 50 adults with type 2 diabetes. Participants previously received a sham (fake) procedure in an earlier study. The goal is to see if the device is safe and works well for managing diabetes.
Matched conditions: TYPE2DIABETES
Phase: NA • Sponsor: Endogenex, Inc. • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
Free produce program aims to prevent diabetes in At-Risk adults
Prevention Not yet recruitingThis study tests whether giving free fruits and vegetables to adults at risk for type 2 diabetes helps them stick to a diabetes prevention program and improve their health. One hundred adults with prediabetes and a high BMI will receive produce plus coaching on diet and exercise.…
Matched conditions: TYPE2DIABETES
Phase: NA • Sponsor: Virginia Commonwealth University • Aim: Prevention
Last updated May 26, 2026 04:35 UTC
-
New registry tracks Real-World safety of diabetes device
Knowledge-focused Not yet recruitingThis study is a registry that collects long-term safety information from people with type 2 diabetes who have already been treated with the Endogenex System. Researchers will track device- and procedure-related side effects over time. About 500 participants will provide their med…
Matched conditions: TYPE2DIABETES
Sponsor: Endogenex, Inc. • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC
-
Gene tweak may explain diabetes risk, new study hopes to find out
Knowledge-focused Not yet recruitingThis study looks at how a specific gene change (rs7903146) affects the body's ability to produce insulin and control blood sugar. Researchers will give 80 healthy adults a drug that blocks a hormone called GLP-1 to see how their pancreas responds. The goal is to understand why th…
Matched conditions: TYPE2DIABETES
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC